M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B

The transcytotic capability and expression of distinct carbohydrate receptors on the intestinal M-cells render it a potential portal for the targeted oral vaccine delivery. PLGA nanoparticles loaded with HBsAg were developed and antigen was stabilized by co-encapsulation of trehalose and Mg(OH)2. Additionally, Ulex europaeus 1 (UEA-1) lectin was anchored to the nanoparticles to target them to M-cells of the peye's patches. The developed systems was characterized for shape, size, polydispersity index and loading efficiency. Bovine submaxillary mucin (BSM) was used as a biological model for the in vitro determination of lectin activity and specificity. The targeting potential of the lectinized nanoparticles were determined by Confocal Laser Scanning Microscopy (CLSM) using dual staining technique. The immune stimulating potential was determined by measuring the anti-HBsAg titre in the serum of Balb/c mice orally immunized with various lectinized formulations and immune response was compared with the alum-HBsAg given intramuscularly. Induction of the mucosal immunity was assessed by estimating secretary IgA (sIgA) level in the salivary, intestinal and vaginal secretion. Additionally, cytokines (interleukin-2; IL-2 and interferon-γ; IFN-γ) level in the spleen homogenates was also determined. The results suggest that HBsAg can be successfully stabilized by co-encapsulation of protein stabilizers. The lectinized nanoparticles have demonstrated approximately 4-fold increase in the degree of interaction with the BSM as compared to plain nanoparticles and sugar specificity of the lectinized nanoparticles was also maintained. CLSM showed that lectinized nanoparticles were predominantly associated to M-cells. The serum anti-HBsAg titre obtained after oral immunization with HBsAg loaded stabilized lectinized nanoparticles was comparable with the titre recorded after alum-HBsAg given intramuscularly. The stabilized UEA-1 coupled nanopartilces exhibited enhanced immune response as compared to stabilized non-lectinized nanoparticles. Furthermore, the stabilized lectinized nanoparticles elicited sIgA in the mucosal secretion and IL-2 and IFN-γ in the spleen homogenates. These stabilized lectinized nanoparticles could be a promising carrier-adjuvant for the targeted oral-mucosal immunization.

[1]  I. M. Belyakov,et al.  Strategies for designing and optimizing new generation vaccines , 2001, Nature Reviews Immunology.

[2]  E. Untersmayr,et al.  Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes. , 2004, Biochemical and biophysical research communications.

[3]  A. Nakane,et al.  Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice , 1992, Infection and immunity.

[4]  K. Griebenow,et al.  Improved activity and stability of lysozyme at the water/CH2CI2 interface: enzyme unfolding and aggregation and its prevention by polyols , 2001, The Journal of pharmacy and pharmacology.

[5]  S. Sahoo,et al.  Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[6]  A. Jones,et al.  Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. , 1996, Pharmaceutical research.

[7]  M. Isaka,et al.  Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. , 2001, Vaccine.

[8]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[9]  E. Lavelle,et al.  Immunological Implications of the use of Plant Lectins for Drug and Vaccine Targeting to the Gastrointestinal Tract , 2004, Journal of drug targeting.

[10]  J L Pedraz,et al.  Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. , 2002, Vaccine.

[11]  J. Cleland,et al.  Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.

[12]  I. Ezpeleta,et al.  Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique , 1996 .

[13]  B. Hirst,et al.  Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. , 1998, Vaccine.

[14]  E. Untersmayr,et al.  Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin. , 2005, Vaccine.

[15]  S. Vyas,et al.  Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. , 2001, Critical reviews in therapeutic drug carrier systems.

[16]  M. Wirth,et al.  Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[17]  O’Hagan,et al.  Microparticles and polymers for the mucosal delivery of vaccines. , 1998, Advanced drug delivery reviews.

[18]  D. Prabakaran,et al.  Development of a single‐dose stabilized poly(d,l‐lactic‐co‐glycolic acid) microspheres‐based vaccine against hepatitis B , 2004, The Journal of pharmacy and pharmacology.

[19]  G. Ponchel,et al.  Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. , 2001, International journal of pharmaceutics.

[20]  F. Brodsky,et al.  The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.

[21]  S. Vyas,et al.  Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.

[22]  Robert Langer,et al.  Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers , 1996, Pharmaceutical Research.

[23]  M. Wirth,et al.  Lectin-Mediated Bioadhesion: Preparation, Stability and Caco-2 Binding of Wheat Germ Agglutinin-Functionalized Poly(D,L-lactic-co-glycolic acid)-Microspheres , 2000, Journal of drug targeting.

[24]  J. Benoit,et al.  Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process. , 1997, Biomaterials.

[25]  S. Honda,et al.  Common conditions for high-performance liquid chromatographic microdetermination of aldoses, hexosamines, and sialic acids in glycoproteins. , 1984, Analytical biochemistry.

[26]  A. Coombes,et al.  The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[27]  M. Yeh,et al.  Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[28]  S. P. Vyas,et al.  Preparation, characterization and in vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intra-periodontal pocket delivery. , 2001, Die Pharmazie.

[29]  A. Goyal,et al.  Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. , 2006, International journal of pharmaceutics.

[30]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[31]  N Hussain,et al.  Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.

[32]  M. Jepson,et al.  Studying M cells and their role in infection. , 1998, Trends in microbiology.

[33]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[34]  H. Marcotte,et al.  Oral Microbial Ecology and the Role of Salivary Immunoglobulin A , 1998, Microbiology and Molecular Biology Reviews.

[35]  P. Sansonetti,et al.  M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. , 1999, Seminars in immunology.

[36]  M. Wolf,et al.  Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. , 2003, Vaccine.

[37]  E. Lavelle,et al.  The identification of plant lectins with mucosal adjuvant activity , 2001, Immunology.

[38]  E. Untersmayr,et al.  M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[39]  Jerry M. Lefkowitz,et al.  A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. , 1984, Journal of immunological methods.

[40]  W. Koff,et al.  Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. , 1997, Vaccine.

[41]  G. Russell-Jones,et al.  Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding , 1988, The Journal of experimental medicine.

[42]  G. Russell-Jones,et al.  The potential use of receptor-mediated endocytosis for oral drug delivery. , 2001, Advanced drug delivery reviews.

[43]  D. Volkin,et al.  Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. , 2002, Journal of pharmaceutical sciences.

[44]  B. Hirst,et al.  Differential expression of lectin-binding sites defines mouse intestinal M-cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.